1. The C19 mRNA injections have never been successfully trialled on animals or humans, nor have they been manufactured to good manufacturing standards. As such, they are a completely new and experimental technology that we have granted emergency use authorization.

2. We did not recommend any other treatment protocols for off-label or emergency use (such as IVM and HCQ treatment protocols) as they would prevent our emergency use authorization of the C19 mRNA injections you are about to take. Many of these treatment protocols have demonstrated safety and effectiveness for prophylaxis, early to mid stage cures and some efficacy in late stages of C19 disease. Emergency use authorization was based on results of Phase 3 clinical trials that were terminated four months into the six month stipulated trial period – that is, 2 months before trials were completed.

3. The two dose regimen of C19 mRNA injections you are about to take has not been tested to see if it prevents infection or transmission.

4. The clinical trials indicated that for every 100 people that receive the two dose initial course, ONE infection will be prevented. (Absolute Risk Reduction of 1%, though I have seen some reports of around 0.5%),

5. Other results – beyond the clinical trial indicate that it would take between 600 (Pfizer) and 900 (Moderna) C19 mRNA injections to prevent a single hospitalization from the C19 disease itself. (Need to check if that was doses or people – if 2 doses per person that would be 300 to 450 people, I think it was doses).

6. Whilst no adverse events from other treatment protocols (such as IVM and HCQ) were seen, Phase 3 clinical trials for Pfizer indicated that around 25% of people experience an adverse event from the C19 mRNA injection, which is 3 times more than the placebo group.

7. 1.2% of those injected suffered a life altering (severe) even – compared to 0.7& in the placebo group.

8. 0.6% of those injected suffered a life threatening event v 0.5% in the placebo.

9. 20 out of 21,926 people died in the injected group v 14 in the placebo.

10. The above comparisons are for a two dose initial course. The injections wane after 4-6 months after which time, you will require additional injections.

11. The injections will force the emergence of variants for which the injections will be ineffective.

12. The manufacturers of the C19 mRNA injections have no liability for harms caused. There are two vaccine injury compensation schemes that do not pay out much if anything.

13. The manufacturers have no responsibility for varying quality of injections and can vary the contents to be markedly different from the clinical trials as they please (typical Pfizer contract here: 25 Page Pfizer contract to EU member state, Slovenia (substack.com) ““..the Vaccine and materials related to the Vaccine and materials related to the Vaccine, and their components and constituent materials are being rapidly developed..”

14. Each dose shuts down your immune system for 14 days, during which time you will be susceptible to any infection of any kind, including C19. It is likely that adverse events will effectively reduce your immune system capability by 25%.

Peter halligan

https://peterhalligan.substack.com/p/so-what-exactly-would-have-informed?utm_source=post-email-title&publication_id=1032096&post_id=133086547&isFreemail=false&utm_medium=email